Blog2024-07-01T14:28:28-05:00

Attend the special discussion group: ASV Therapy for CSA Patients with Heart Failure

On Monday, June 8, at SLEEP 2015 in Seattle, a special discussion group will be held to review the preliminary findings of the SERVE-HF study, which indicate that there is an increased risk of cardiovascular death with ASV treatment for patients with central sleep apnea syndrome; symptomatic, chronic heart failure; and a reduced left ventricular ejection fraction.

June 4th, 2015|Professional Development|

Hypnogram: MOC efforts are gaining momentum

The voices of sleep physicians have been heard loud and clear.  That is the theme of recent correspondence received by the American Academy of Sleep Medicine from the American Board of Internal Medicine (ABIM) regarding its Maintenance of Certification (MOC) program.

June 3rd, 2015|Thought Leaders|
Go to Top